National Academies Press: OpenBook
« Previous: 5 Management of Science and Technology at CBDP
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

Appendix A


Schedule of Data-Gathering

Data Gathering Meeting 1: February 29-March 1, 2012 in Washington, DC

The committee received overview presentations of the CBDP from the following people:

Dr. Gerald Parker, Deputy Assistant Secretary of Defense for Chemical and Biological Defense

Dr. Robert Cohn, Chief Scientist, Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs/Chemical and Biological Defense

BG Lucas Polakowski, Deputy Director for Force Protection and Counter Weapons of Mass Destruction, J8

BG Jess Scarborough, Joint Program Executive Officer for Chemical and Biological Defense

Mr. James Cooke, Deputy Under Secretary of the Army for Test and Evaluation

Mr. Lenny Izzo, Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense

Dr. Alan Rudolph, Director, Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA)

In addition to these individuals, the committee heard panel presentations focused on specific capability focus areas. Participants in these panels came from multiple offices from throughout the CBDP enterprise. The

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

focus areas were Surveillance, Medical Countermeasures, Enabling Technologies, and Hazard Mitigation. The committee also received a threat assessment briefing.

Data Gathering Meeting 2: March 15, 2012 in Dugway, UT

A subgroup of the committee visited Dugway Proving Ground in Dugway, UT. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The group also held roundtable discussions with local project managers, senior scientists, and management personnel. The committee toured the Materiel Test Facility, the Combined Chemical Test Facility, the Life Sciences Test Facility, and the Joint Ambient Breeze Tunnel.

The committee met with the following individuals:

COL A. Scott Estes, Commander, DPG

SGM Stanley Morton, Jr., Command Sergeant Major, DPG

Dr. Kenneth Gritton, Technical Director, WDTC

Mr. Ryan Harris, Acting Director, WDTC

Mr. Chris Johnson, Chief, WDTC Operations Division

Dr. Chris Olson, Chief, WDTC Chemical Test Division

Mr. Jeff Garcia, Acting Chief, WDTC Dissemination & Explosives Division

Dr. Doug Andersen, Chief, WDTC Life Sciences Division

Mr. Ross Rosengren, Chief, Resource Management

Mr. Bill Brown, Test Engineering & Integration Division

Data Gathering Meeting 3: March 16, 2012 in Natick, MA

A subgroup of the committee visited the US Army Natick Soldier Research, Development, and Engineering Center in Natick, MA. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The group also participated in a roundtable discussion with principle investigators and senior scientists. The committee toured and met with personnel from the following programs: Human Factors Lab and Assessment, the Molecular Science & Engineering Team, ARIEM and the Doriot Chambers, and Collective Protection and Shelters. The committee met with individuals, including: Dr. Heidi Gibson, Natick Soldier Research, Development and Engineering Center, Polymer Research Chemist.

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

Data Gathering Meeting 4: March 19-20, 2012 at Various Locations

March 19, Washington, DC

The committee heard a number of briefings from representatives from agencies and individuals that have programs relevant to the CBDP initiatives or capability focus areas.

Robert Kadlec, RPK Consulting LLC

Randall Long, Director, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security

Susan Coller-Monarez, Threat Characterization and Attribution Branch Chief, Chemical and Biological Defense Division Science and Technology Directorate, Department of Homeland Security

Elizabeth George, Director of the Cooperative Threat Reduction Directorate, Defense Threat Reduction Agency, Department of Defense

Carol Linden, Principal Deputy Director, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services

Mike Kurilla, Director, Office of BioDefense Research Affairs, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Rick Jaffe, Director, Medical Countermeasures, Strategy, and Requirements, Office of Policy and Planning, Health and Human Services

Luciana Borio, Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats, Food and Drug Administration

March 20, Frederick, MD

A subgroup of the committee visited US Army Medical Research Institute for Infectious Diseases (USAMRIID) at Ft. Detrick in Frederick, MD. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The committee also toured BSL-2, BSL-4, and ECO facilities and toured the aerobiology laboratory. During the meeting, the group also participated in roundtable discussions with the senior scientists, program managers, and management personnel.

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

The committee met with the following individuals:

COL Bernard DeKoning, Commander

COL Andrea Stahl, Deputy Commander

COL Brian Gentile, Director for Administration

SGM Thomas Tuttle, Sergeant Major

Dr. Leonard Smith, Acting Science Director

Dr. Connie Schmaljohn, Senior Research Scientist

Dr. Arthur Friedlander, Supervisory Research Medical Officer

Dr. Mark Dertzbaugh, Chief, Business Plans and Programs

COL Fernando Guerena, Chief, Division of Medicine

LTC Neal Woollen, Director of Safety, Security, and Biosurety

Dr. David Norwood, Chief, Diagnostic Systems Division

Dr. Jeffrey Teska, NICBR Partnership Office

Dr. Aysegul Nalca, Chief, Center for Aerobiological Sciences

Dr. Patricia Worsham, Chief, Bacteriology Division

Dr. Louise Pitt, Chief, Virology Division

Dr. Sina Bavari, Chief, Integrated Toxicology Division

Mr. James Coffman, Chief, Office of Research and Technology Applications

Ms. Caree Vander Linden, Public Affairs Office

COL Randall Rietcheck, Director, Veterinary Medicine Division

LTC Pedro Rico, Chief, Pathology Division

March 20, Aberdeen, MD

A subgroup of the committee visited US Army Medical Research Institute for Chemical Defense (USAMRICD) and Edgewood Chemical Biological Center (ECBC) at Aberdeen Proving Ground in Aberdeen, MD. The group met with representatives, took tours of the facilities, and heard overview presentations about the site’s capabilities and activities.

At USAMRICD, the committee toured the laboratories and facilities for molecular modeling, chemical surety, behavioral studies, mass spectrometry and analytical chemistry, and the vivarium. The presentations and tours were led by the following people:

COL Peter Schultheiss, Commander

COL Deborah Whitmer, Deputy Commander

Dr. John Graham, Deputy to the Commander for Research

Dr. James Dillman, Chief, Research Program Office

Dr. Doug Cerasoli, Program Advisor, Molecular and Cellular Therapeutics

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

Dr. Lucille Lange, Program Advisor, Toxicologic Modeling

LTC Rick Probst, Deputy Chief, Research Support Division

Dr. Ben Capacio, Program Advisor, Medical Diagnostics and Forensics

Mr. Jonathon Oyler, Chemist, Team Leader for BB Area

The committee also met with program advisors and deputy program advisors, division chiefs and deputy division chiefs, and management personnel for a roundtable discussion.

At ECBC the committee toured the McNamara Life Science Building, which houses the inhalation chamber, the standoff detection team, the genomics laboratory, and BSL-3 laboratories; the Mobile Laboratory Systems; the Advanced Chemistry Laboratory, which houses Decontamination Science, the Filter Testing Laboratory, and the Synthesis Laboratory; and the Sample Receipt Facility. Following the facility tours, committee members met with the principle investigators for wrap-up discussions then returned to the original meeting room for a roundtable discussion with facility management personnel.

The presentations and tours were led by the following people:

Dr. Joseph Corriveau, Director, Research and Technology

COL Ray Compton, Military Deputy

Dr. John Carpin, Biomedical Engineer

Dr. Christopher Whalley, (Acting) Division Chief, Toxicology and Obscurants

Dr. Mary Wade, (Acting) Branch Chief, BioDefense

Mr. Richard Vanderbeek, Branch Chief, Laser Standoff Detection

Dr. Sandy Gibbons, Research Microbiologist

Dr. Carrie Poore, Team Leader, Advanced CBRNE Training Team

Mr. George Noya, Team Leader, Mobile Labs and Kits Team

Dr. Teri Lalain, Branch Chief, Decontamination Sciences

Dr. Brent Mantooth, Principle Investigator, Modeling Simulation and Analysis

Mr. Matt Shue, (Acting) Branch Chief, Decontamination Sciences

Dr. Frederick Cox, (Acting) Division Chief, CB Protection and Decontamination

Dr. Fred Berg, Division Chief, Chemical Sciences

Mr. Chris Druyor, Chemical Engineering Technician

Mr. Jerry Pfarr, Microbiologist, Chemical Operations Branch

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×

Data Gathering Meeting 5: April 3, 2012 in Washington, DC

The committee invited representatives from all of the DOD Combatant Commands and the Services to brief the group on their perspectives on the CBD Program and its objectives and capabilities. At its fifth meeting, the committee held discussions with representatives from US European Command and US Northern Command. The committee also spoke with US DOD Service representatives to the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense from the US Army and US Marines. Due to unforeseen circumstances, US Strategic Command and the Service representative from the US Air Force were unable to participate.

At this meeting, the committee also held roundtable discussions with program managers from the Joint Science Technology Office and the Joint Program Executive Office for Chemical and Biological Defense.

The committee was also briefed by Dr. Julie Pavlin, Deputy Director, Armed Forces Health Surveillance Center (AFHSC) and Acting Chief, Global Emerging Infections Surveillance & Response System (GEIS), on GEIS and its activities.

Data Gathering Meeting 6: April 18, 2012 in Washington, DC

The committee held discussions with representatives from US Special Operations Command on the CBD Program and its objectives and capabilities.

Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 105
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 106
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 107
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 108
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 109
Suggested Citation:"Appendix A; Schedule of Data-Gathering." National Research Council. 2012. Determining Core Capabilities in Chemical and Biological Defense Science and Technology. Washington, DC: The National Academies Press. doi: 10.17226/13516.
×
Page 110
Next: Appendix B: Additional Thoughts on the Nature of the Chemical Threat »
Determining Core Capabilities in Chemical and Biological Defense Science and Technology Get This Book
×
Buy Paperback | $45.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The goal of the U.S. Department of Defense's (DoD's) Chemical and Biological Defense Program (CBDP) is to provide support and world-class capabilities enabling he U.S. Armed Forces to fight and win decisively in chemical, biological, radiological, and nuclear (CBRN) environments. To accomplish this objective, the CBDP must maintain robust science and technology capabilities to support the research, development, testing, and evaluation required for the creation and validation of the products the program supplies.

The threat from chemical and biological attack evolves due to the changing nature of conflict and rapid advances in science and technology (S&T), so the core S&T capabilities that must be maintained by the CBDP must also continue to evolve. In order to address the challenges facing the DoD, the Deputy Assistant Secretary of Defense (DASD) for Chemical and Biological Defense (CBD) asked the National Research Council (NRC) to conduct a study to identify the core capabilities in S&T that must be supported by the program.

The NRC Committee on Determining Core Capabilities in Chemical and Biological Defense Research and Development examined the capabilities necessary for the chemical and biological defense S&T program in the context of the threat and of the program's stated mission and priorities. Determining Core Capabilities in Chemical and Biological Defense Science and Technology contains the committee's findings and recommendations. It is intended to assist the DASD CBD in determining the best strategy for acquiring, developing, and/or maintaining the needed capabilities.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!